Evidence map›Paper›PMID 42265278›Full record

ArticleNPJ digital medicine2026

Forecasting Alzheimer's disease progression via identity-preserved denoising diffusion generative adversarial network.

Zhuangzhuang Li, Tongtong Che, Shaozhen Yan, Dong Wang, Yong Liu, Kun Zhao

Abstract read
In one paragraph

Article in NPJ digital medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Zhuangzhuang LiSchool of Artificial Intelligence, Beijing University of Posts and Telecommunications, Beijing, China.
Tongtong CheState Key Laboratory of Cognitive Neuroscience and Learning, Beijing Normal University, Beijing, China.
Shaozhen YanDepartment of Radiology, Xuanwu Hospital of Capital Medical University, Beijing, China.
Dong WangSchool of Artificial Intelligence, Beijing University of Posts and Telecommunications, Beijing, China.
Yong LiuSchool of Artificial Intelligence, Beijing University of Posts and Telecommunications, Beijing, China. yongliu@bupt.edu.cn.
Kun ZhaoSchool of Artificial Intelligence, Beijing University of Posts and Telecommunications, Beijing, China. kunzhao@bupt.edu.cn.

Funding

Beijing Municipal Natural Science Foundation No. 7244519BUPT Excellent Ph.D. Students Foundation No. CX2023117National Natural Science Foundation of China No. 82401858National Natural Science Foundation of China No. T2425027
6 · The paper itself

Abstract

Forecasting the progression of Alzheimer's disease (AD) is essential for evaluating secondary prevention measures thought to modify the disease trajectory. However, accurate prediction of longitudinal MRIs remains challenging, particularly in preserving subject identity, as deep generative models may potentially generate plausible future MRIs of different individuals from a single baseline scan. In the present study, we developed a novel identity-preserved denoising diffusion generative adversarial network (IP-DDGAN) capable of rapidly generating subject-specific longitudinal MRIs conditioned on metadata. Concretely, we developed an identity-preservation strategy incorporating a metadata-guided module and identity-preserved regularization terms to maintain subject identity in synthetic longitudinal MRIs. Furthermore, we comprehensively integrated morphometric, subject-identity-consistency, and image-level quality metrics to evaluate the fidelity and biological plausibility of synthetic longitudinal MRIs. The results demonstrate that the synthetic MRIs generated by IP-DDGAN retain biological and disease-related phenotypes and exhibit sufficient realism to support downstream applications. Our proposed model effectively captures temporal biological and disease-related changes and predicts distinct disease progression trajectories, including the clinically important transitions from cognitively normal (CN) to mild cognitive impairment (MCI) and from MCI to AD.

Identifiers

PMID42265278
PMCPMC13586159

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.